Annual Operating Profit
-$107.36 M
-$22.51 M-26.52%
December 31, 2021
Summary
- As of February 10, 2025, PHAS annual operating income is -$107.36 million, with the most recent change of -$22.51 million (-26.52%) on December 31, 2021.
- During the last 3 years, PHAS annual operating profit has fallen by -$87.72 million (-446.54%).
Performance
PHAS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Profit
-$25.31 M
-$7.08 M-38.86%
June 30, 2022
Summary
- As of February 10, 2025, PHAS quarterly operating income is -$25.31 million, with the most recent change of -$7.08 million (-38.86%) on June 30, 2022.
- Over the past year, PHAS quarterly operating profit has dropped by -$4.26 million (-20.23%).
Performance
PHAS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Operating Profit
-$104.20 M
-$4.26 M-4.26%
June 30, 2022
Summary
- As of February 10, 2025, PHAS TTM operating income is -$104.20 million, with the most recent change of -$4.26 million (-4.26%) on June 30, 2022.
- Over the past year, PHAS TTM operating profit has dropped by -$11.03 million (-11.84%).
Performance
PHAS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
PHAS Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.5% | -20.2% | -11.8% |
| 3 y3 years | -446.5% | -166.9% | -162.2% |
| 5 y5 years | -1157.5% | -1235.7% | -162.2% |
PHAS Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +38.9% | +26.8% | +4.3% | +3.0% |
| 5 y | 5-year | +170.2% | at low | +124.4% | +26.8% | +162.2% | +3.0% |
| alltime | all time | +1157.5% | at low | +1235.7% | +26.8% | +5398.8% | +3.0% |
PhaseBio Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$25.31 M(+38.9%) | -$104.20 M(+4.3%) |
| Mar 2022 | - | -$18.23 M(-43.2%) | -$99.94 M(-6.9%) |
| Dec 2021 | -$107.36 M(+26.5%) | -$32.09 M(+12.3%) | -$107.36 M(+6.0%) |
| Sep 2021 | - | -$28.58 M(+35.7%) | -$101.25 M(+8.7%) |
| Jun 2021 | - | -$21.05 M(-17.9%) | -$93.17 M(-3.2%) |
| Mar 2021 | - | -$25.65 M(-1.3%) | -$96.22 M(+13.4%) |
| Dec 2020 | -$84.86 M(+113.5%) | -$25.98 M(+26.8%) | -$84.86 M(+20.9%) |
| Sep 2020 | - | -$20.49 M(-15.0%) | -$70.16 M(+14.5%) |
| Jun 2020 | - | -$24.10 M(+68.7%) | -$61.26 M(+31.3%) |
| Mar 2020 | - | -$14.29 M(+26.7%) | -$46.64 M(+17.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$39.74 M(+102.3%) | -$11.28 M(-2.7%) | -$39.74 M(+10.0%) |
| Sep 2019 | - | -$11.59 M(+22.2%) | -$36.12 M(+22.3%) |
| Jun 2019 | - | -$9.48 M(+28.4%) | -$29.52 M(+22.3%) |
| Mar 2019 | - | -$7.38 M(-3.6%) | -$24.15 M(+22.9%) |
| Dec 2018 | -$19.64 M(+130.1%) | -$7.66 M(+53.2%) | -$19.64 M(+36.1%) |
| Sep 2018 | - | -$5.00 M(+21.7%) | -$14.44 M(+27.4%) |
| Jun 2018 | - | -$4.11 M(+42.7%) | -$11.33 M(+56.9%) |
| Mar 2018 | - | -$2.88 M(+17.4%) | -$7.22 M(+66.2%) |
| Dec 2017 | -$8.54 M(-10.1%) | -$2.45 M(+29.3%) | -$4.35 M(+129.3%) |
| Sep 2017 | - | -$1.90 M | -$1.90 M |
| Dec 2016 | -$9.50 M | - | - |
FAQ
- What is PhaseBio Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual operating profit year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly operating profit year-on-year change?
- What is PhaseBio Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals TTM operating profit year-on-year change?
What is PhaseBio Pharmaceuticals annual operating income?
The current annual operating profit of PHAS is -$107.36 M
What is the all time high annual operating profit for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual operating income is -$8.54 M
What is PhaseBio Pharmaceuticals annual operating profit year-on-year change?
Over the past year, PHAS annual operating income has changed by -$22.51 M (-26.52%)
What is PhaseBio Pharmaceuticals quarterly operating income?
The current quarterly operating profit of PHAS is -$25.31 M
What is the all time high quarterly operating profit for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly operating income is -$1.90 M
What is PhaseBio Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, PHAS quarterly operating income has changed by -$4.26 M (-20.23%)
What is PhaseBio Pharmaceuticals TTM operating income?
The current TTM operating profit of PHAS is -$104.20 M
What is the all time high TTM operating profit for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high TTM operating income is -$1.90 M
What is PhaseBio Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, PHAS TTM operating income has changed by -$11.03 M (-11.84%)